Home » Authors » Karen Young

Articles by Karen Young

GenPath Raises $15.5M In Series A To Study Cancer Genes, Pathways

May 20, 2002

Trimeris Plans Filing Based On Positive T-20 Phase III Results

May 17, 2002

Deltagen Raises $25.3M Privately To Push Internal Drug Discovery

May 17, 2002

Trimeris Plans Filing Based On Positive T-20 Phase III Results

May 17, 2002

Deltagen Raises $25.3M Privately To Push Internal Drug Discovery

May 17, 2002

Hyseq, BASF To Finish Deal Early; Hyseq Cutting Employees

May 16, 2002

Nexell's Board OKs Orderly Wind-Down' Of Operations

May 16, 2002

Hyseq, BASF To Finish Deal Early; Hyseq Cutting Employees

May 16, 2002

Nexell's Board OKs Orderly Wind-Down' Of Operations

May 16, 2002

Emisphere's Oral Heparin Fails In Phase III Against Lovenox

May 15, 2002

Emisphere Technologies Inc. said Tuesday that its Phase III trial of oral heparin failed to show superiority to Aventis SA's injected Lovenox in preventing deep-vein thrombosis in patients undergoing total hip replacement surgery. (BioWorld Today)